United States - English - NLM (National Library of Medicine)

northstar rxllc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin and benzoyl peroxide gel is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

United States - English - NLM (National Library of Medicine)

dermalogica, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 50 mg in 1 ml - acne treatment - treats acne

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin phosphate and benzoyl peroxide gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. clindamycin phosphate and benzoyl peroxide gel is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel [see postmarketing experience (6.2)] . clindamycin phosphate and benzoyl peroxide gel is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis [seewarnings and precautions (5.1)] . risk summary there are no available data on clindamycin phosphate and benzoyl peroxide gel use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. the limited published data on use of clindamycin in pre

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin 10 mg in 1 g - clindamycin and benzoyl peroxide topical gel is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide topical gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

United States - English - NLM (National Library of Medicine)

sol-gel technologies inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - epsolay is indicated for the treatment of inflammatory lesions of rosacea in adults. epsolay is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in epsolay [see warnings and precautions (5.1)]. risk summary the systemic exposure of benzoyl peroxide is unknown. based on the published literature, benzoyl peroxide is metabolized to benzoic acid (an endogenous substance), which is eliminated in the urine. hence, maternal use is not expected to result in fetal exposure to the drug. animal reproductive studies have not been conducted with epsolay or benzoyl peroxide. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk s

United States - English - NLM (National Library of Medicine)

cintex services, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - for the treatment of acne - have very sensitive skin - are sensitive to benzoyl peroxide stop use and ask a doctor if   irritation becomes severe.

United States - English - NLM (National Library of Medicine)

cintex services, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 98 mg in 1 g - acne treatment for the treatment of acne do not use if you - have very sensitive skin - are sensitive to benzoyl peroxide stop use and ask a doctor if irritation becomes severe.

United States - English - NLM (National Library of Medicine)

axia medical solutions, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 50 mg in 1000 mg - acne treatment for the treatment of acne. • have sensitive skin. • are sensitive to benzoyl peroxide. irritation become severe.

United States - English - NLM (National Library of Medicine)

axia medical solutions, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - acne treatment for the treatment of acne. • have sensitive skin. • are sensitive to benzoyl peroxide. irritation become severe.

United States - English - NLM (National Library of Medicine)

vetoquinol usa, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 25 mg in 1 ml - indicated for topical therapy of pyoderma, folliculitis and seborrhea complex. may be used as a moisturizing, antiseptic shampoo for routine use as directed by your veterinarian. for pretreatment cleansing, micro pearls® advantage hydra pearls™ shampoo may be used prior to the application of benzoyl plus™.